Interleukin-2 Receptor Levels in Non-Hodgkin's Lymphoma Correlation to histological degree of malignancy and presence of constitutional symptoms

Authors

  • J. M. Tangen Departments of Oncology and Medicine, Ullevål Hospital, and the Norwegian Radium Hospital, Oslo; The Department of Oncology, Haukeland Hospital, Bergen, Norway
  • A. Foss Abrahamsen Departments of Oncology and Medicine, Ullevål Hospital, and the Norwegian Radium Hospital, Oslo; The Department of Oncology, Haukeland Hospital, Bergen, Norway
  • B. Østenstad Departments of Oncology and Medicine, Ullevål Hospital, and the Norwegian Radium Hospital, Oslo; The Department of Oncology, Haukeland Hospital, Bergen, Norway
  • J. Bergheim Departments of Oncology and Medicine, Ullevål Hospital, and the Norwegian Radium Hospital, Oslo; The Department of Oncology, Haukeland Hospital, Bergen, Norway

DOI:

https://doi.org/10.3109/02841869009090055

Keywords:

Non-Hodgkin’s lymphoma, histopathology, consti- tutional symptoms, interleukin-2 receptor

Abstract

Serum interleukin-2 receptor (Il-2R) levels were measured in 28 untreated patients with stage III or IV non-Hodgkin's lymphoma (low grade lymphoma: n=11, high grade lymphoma: n=17). Markedly higher levels of Il-2R were found in these patients compared to an age- and sexmatched control group. Significant differences were also found between the high grade group and the low grade group, and between patients with and without constitutional (B) symptoms. It has previously been shown that Il-2R levels vary according to tumor burden in patients with non-Hodgkin's lymphoma. Our data indicate that histological degree of malignancy as well as presence or absence of B symptoms may also influence Il-2R levels in these patients. All three parameters should therefore be taken into account when the clinical significance of Il-2R levels is evaluated.

Downloads

Download data is not yet available.

Downloads

Published

1990-01-01

How to Cite

Tangen, J. M., Foss Abrahamsen, A., Østenstad, B., & Bergheim, J. (1990). Interleukin-2 Receptor Levels in Non-Hodgkin’s Lymphoma Correlation to histological degree of malignancy and presence of constitutional symptoms. Acta Oncologica, 29(5), 581–583. https://doi.org/10.3109/02841869009090055